Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study
In: American Journal of Transplantation, Jg. 21 (2021), Heft 9, S. 3055-3065
academicJournal
Zugriff:
Titel: |
Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study
|
---|---|
Autor/in / Beteiligte Person: | Reinders, Marlies E.J. ; Groeneweg, Koen E. ; Hendriks, Sanne H. ; Bank, Jonna R. ; Dreyer, Geertje J. ; de Vries, Aiko P.J. ; van Pel, Melissa ; Roelofs, Helene ; Huurman, Volkert A.L. ; Meij, Paula ; Moes, Dirk J.A.R. ; Fibbe, Willem E. ; Claas, Frans H.J. ; Roelen, Dave L. ; van Kooten, Cees ; Kers, Jesper ; Heidt, Sebastiaan ; Rabelink, Ton J. ; de Fijter, Johan W. ; Astellas Pharma Global Development ; Pharma, Novartis ; ZonMw |
Link: | |
Zeitschrift: | American Journal of Transplantation, Jg. 21 (2021), Heft 9, S. 3055-3065 |
Veröffentlichung: | Elsevier BV, 2021 |
Medientyp: | academicJournal |
ISSN: | 1600-6135 |
DOI: | 10.1111/ajt.16528 |
Schlagwort: |
|
Sonstiges: |
|